Literature DB >> 15983926

Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality.

Janice K Louie1, Shigeo Yagi, Fritzi A Nelson, David Kiang, Carol A Glaser, Jon Rosenberg, Christine K Cahill, David P Schnurr.   

Abstract

During a 6-week period in 2003, 56 residents and 26 staff developed respiratory illness in a long-term facility; 12 residents died. Seven of 13 respiratory specimens were culture-positive for rhinovirus; 6 of the isolates were serotype 82. In elderly populations, severe illness may be associated with organisms typically considered to be "benign," such as rhinovirus.

Entities:  

Mesh:

Year:  2005        PMID: 15983926      PMCID: PMC7107978          DOI: 10.1086/430915

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


Rhinovirus infections may account for up to one-third of cases of “common cold.” The virus has >100 serotypes, is ubiquitous, and can cause repeated episodes of infection throughout an individual's lifetime [1]. Although infection in otherwise healthy persons is frequently self-limited, certain populations may be predisposed to severe manifestations, including bronchiolitis and pneumonia in infants and exacerbations of pre-existing airway disease in persons with chronic obstructive lung disease, asthma, and cystic fibrosis [2]. With the development of sensitive PCR techniques, there is an increasing number of reports of severe rhinovirus infection in other populations, including elderly persons [3]. We describe a large outbreak of respiratory illness in a long-term care facility (LTCF) attributed to rhinovirus and the associated high morbidity and mortality. . In June 2003, an outbreak of respiratory illness in a 99-bed LTCF was reported to the local health department and the California Department of Health Services. The LTCF performed routine surveillance for respiratory illness year-round by recording daily temperatures and assessing for symptoms. After reporting the outbreak, personnel of the LTCF initiated active surveillance for new cases of respiratory illnesses in residents and staff and, when feasible, collected specimens from ill patients. Epidemiologic and clinical data for residents were obtained by reviewing their medical and hospitalization records, and data for staff were obtained by interview with a standardized questionnaire. Nasopharyngeal swab specimens, sputum samples (from patients who could cough), and serum samples were transported on ice to the California Department of Health Services Viral and Rickettsial Laboratory. Respiratory samples (0.2 mL) were inoculated into primary rhesus monkey kidney and human fetal diploid lung cells with gentamicin (10 µg/mL) and fungizone (1 µg/mL) in roller tubes at 33°C. Cultures were observed daily for 14 days. Hemadsorption with guinea pig RBCs was performed on rhesus monkey kidney cells between 5–7 days and 12–14 days after initiating cultures. Culture-positivity was confirmed by sequencing PCR product from the VP4-VP2 region of the genome. Total nucleic acid was extracted using the MasterPure Complete DNA and RNA Purification Kit (Epicentre Technologies). RT-PCR was performed with reverse primers for respiratory syncytial virus, parainfluenza virus types 1–3 and influenza A and B viruses [4], parainfluenza virus type 4 [5], coronavirus 229E (reverse primer) [6], human metapneumovirus [7], and coronavirus OC43 and coronavirus 229E (forward primers) [8]. The picornavirus primers were supplied by D. Erdman (Centers for Disease Control and Prevention; Atlanta, GA) (forward primer 5′-GGCCCCTGAATG(CT)GGCTAA-3′ and reverse 5′-GAAACACGGACACCCAAAGTA-3′.) Rhinovirus primers were those described by Savolainen et al. [9]. Conventional PCR was performed with Mycoplasma pneumoniae [10] and Chlamydia pneumoniae [11] primers. Available serum samples obtained from patients were tested for detection of IgG antibodies against influenza A and B viruses, respiratory syncytial virus, parainfluenza virus types 2–4, adenovirus, M. pneumoniae, and Chlamydia species using in-house assays and for detection of IgM antibodies by means of an enzyme immunoassay against Chlamydia species [12] and M. pneumoniae (Meridian Biosciences). . All 56 residents living in 2 long-term care units developed respiratory symptoms, for an attack rate of 100%. No residents in an adjacent subacute care unit became ill. The first patient developed symptoms on 15 June 2003. The outbreak lasted 6 weeks and peaked at 10 days after onset when 15 residents developed symptoms. The mean age of the infected residents was 87.6 years. Twenty-six health care workers, 22 of whom were nurses providing direct patient care, became ill in the same period (between 15 June 2003 and 3 July 2003) (figure 1).
Figure 1

Epidemiologic curve of an outbreak of rhinovirus infection among 82 patients and staff at a long-term care facility for elderly persons (n = 82), June–July 2003.

Epidemiologic curve of an outbreak of rhinovirus infection among 82 patients and staff at a long-term care facility for elderly persons (n = 82), June–July 2003. Cases of clinical illness among residents were characterized by fever (temperature, >38.0°C), productive cough, shortness of breath, wheezing, and lethargy. Twenty-six residents (46%) had underlying medical conditions, including chronic cardiac disease [13], chronic lung disease [8], history of cerebrovascular accident [8], and dementia or Alzheimer's disease [10]. Thirty-four residents underwent chest radiography, with 15 residents (27% of all cases) showing evidence of unilobar or multilobar pneumonia. By contrast, the 26 ill health care workers reported symptoms of mild upper respiratory infection with dry cough, sore throat, and subjective, low-grade fever. Thirty-five symptomatic residents received antibiotics orally. One resident was hospitalized. Twelve residents (21%), none of whom was a hospice patient, died, and the cause of death was directly attributed to acute infection. The mean age of deceased residents was 93.6 years, and all residents had at least 1 underlying chronic medical condition. None underwent autopsy. Fifty (89%) of the infected residents had received an influenza vaccination. Thirteen ill residents, including 2 who subsequently died, had nasopharyngeal swab specimens collected within 7 days after the onset of symptoms. A sputum sample was collected from 1 ill resident and sent to the California Department of Health Services Viral and Rickettsial Laboratory; additional sputum specimens obtained from 3 ill residents were sent to the local public health laboratory for testing. Acute and convalescent-phase serum samples were collected from 5 ill residents, including 2 who died. Respiratory specimens were cultured for viruses; 7 of 13 nasopharyngeal swab specimens and the only sputum sample were culture-positive for rhinovirus. One resident with rhinovirus infection had radiographically confirmed pneumonia and died. The remaining residents either had normal chest radiograph findings or did not undergo chest radiography; all had an uneventful recovery. The PCR products from the VP2-4 regions of 6 isolates were sequenced and identified as rhinovirus serogroup 82. At the local public health laboratory, Gram staining and bacterial culture were performed on sputum samples obtained from 3 patients; 2 cultures grew nontypeable Haemophilus influenzae. Neither patient had symptoms suggestive of pneumonia, and both clinically improved. Nasopharyngeal swab specimens obtained from these same patients were cultured at the California Department of Health Services Viral and Rickettsial Laboratory and yielded rhinovirus. Conventional PCR identified picornavirus in 7 of 13 nasopharyngeal swab specimens. Six of 7 were culture-positive for rhinovirus. No other viral pathogens were identified by PCR. All 13 nasopharyngeal swab specimens tested negative for M. pneumoniae and C. pneumoniae by PCR. Five patients underwent the following analyses: serologic testing of acute-phase serum specimens for detection of IgM antibodies against Chlamydia species and M. pneumoniae; and serologic testing of paired serum specimens for detection of IgG antibodies against influenza A and B viruses, respiratory syncytial virus, parainfluenza virus types 2–4, adenovirus, Chlamydia species, and M. pneumoniae. All results were negative. . This report describes an outbreak of respiratory illness attributed to rhinovirus, an organism infrequently associated with severe clinical manifestations or complications. Previous studies of respiratory illness in LTCFs have identified influenza and respiratory syncytial virus as the most common pathogens, with rhinovirus accounting for <10% of cases of infection [12]. Since this outbreak, another outbreak at a LTCF due to rhinovirus associated with 6 cases of radiologically confirmed pneumonia has been reported to the California Department of Health Services (David Schnurr, personal communication). Although other reports have described outbreaks of rhinovirus infection in LTCFs [1], none have observed the high morbidity or mortality rate that we describe. The conclusion that rhinovirus is the causative pathogen is made cautiously. Agents isolated from the nasopharynx may represent asymptomatic colonization rather than true infection, particularly when sensitive PCR detection methods have been used. Because many of these elderly patients had a poor gag reflex and were unable to produce lower respiratory tract specimens, diagnostic testing for bacteria using Gram staining and culture was not routinely performed. H. influenzae was identified by cultures of 2 sputum samples obtained early in the outbreak. It is possible that secondary superinfection with H. influenzae or other bacterial pathogens contributed to the high morbidity and mortality associated with this outbreak. Nevertheless, the microbiologic findings suggest that rhinovirus was the primary causative agent that precipitated the outbreak. This is supported by the lacking evidence of other viral pathogens, the temporally and geographically sharp definition of the outbreak, the observation that health care workers concurrently suffered only mild symptoms, and the discovery that a majority of the rhinovirus isolates were of the same serotype. Almost one-half of our patients had a history of underlying severe cardiopulmonary or neurologic disease; this is consistent with other reports that suggest an increased likelihood of lower respiratory tract complications from rhinovirus infection in patients with chronic underlying illness [3]. Although some studies have suggested that certain antigenically related groups are associated with higher incidence of infection, increased clinical virulence, and prolonged viral shedding, others have not found any relation between the severity of illness and the specific serotypes [14, 15]. A notable exception is rhinovirus 16, which has been associated with bronchial inflammation, airway hyperresponsivness, and asthma exacerbations [16]. Rhinovirus 82 has not been specifically associated with increased virulence in clinical or laboratory studies; further studies on the epidemiologic and clinical characteristics associated with individual serogroups are merited. This report highlights the importance of both strict practice of respiratory hygiene and the early institution of infection-control measures (e.g., isolating and cohorting patients, daily screening for new respiratory illness in residents and staff, restricting flotation of staff between units, and closing residential units to outside visitors) after the identification of respiratory illnesses in LTCFs. Respiratory pathogens, such as rhinovirus, which may cause only mild symptoms in healthy persons, can be a source of major morbidity and mortality in elderly or immunocompromised populations. These agents may be ubiquitous in the health care worker and visitor populations who have contact with these patients. Rigorous respiratory hygiene measures have been strongly advocated in the wake of outbreaks of severe acute respiratory syndrome and influenza, their universal practice can also protect vulnerable patients from what are otherwise considered to be benign pathogens in healthy populations.
  16 in total

1.  Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70.

Authors:  Carita Savolainen; Soile Blomqvist; Mick N Mulders; Tapani Hovi
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

2.  Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.

Authors:  A Pitkäranta; E Arruda; H Malmberg; F G Hayden
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  Evaluation of nested polymerase chain methods for the detection of human coronaviruses 229E and OC43.

Authors:  S Myint; S Johnston; G Sanderson; H Simpson
Journal:  Mol Cell Probes       Date:  1994-10       Impact factor: 2.365

4.  Human metapneumovirus infections in young and elderly adults.

Authors:  Ann R Falsey; Dean Erdman; Larry J Anderson; Edward E Walsh
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

Review 5.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

6.  Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study.

Authors:  B Gröndahl; W Puppe; A Hoppe; I Kühne; J A Weigl; H J Schmitt
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

7.  Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture.

Authors:  C L Hyman; P M Roblin; C A Gaydos; T C Quinn; J Schachter; M R Hammerschlag
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

8.  A rhinovirus outbreak among residents of a long-term care facility.

Authors:  T G Wald; P Shult; P Krause; B A Miller; P Drinka; S Gravenstein
Journal:  Ann Intern Med       Date:  1995-10-15       Impact factor: 25.391

9.  Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCR.

Authors:  J C Aguilar; M P Pérez-Breña; M L García; N Cruz; D D Erdman; J E Echevarría
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 10.  Rhinovirus and the lower respiratory tract.

Authors:  Frederick G Hayden
Journal:  Rev Med Virol       Date:  2004 Jan-Feb       Impact factor: 6.989

View more
  49 in total

1.  Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection.

Authors:  Carla Nisii; Silvia Meschi; Marina Selleri; Licia Bordi; Concetta Castilletti; Maria Beatrice Valli; Eleonora Lalle; Francesco Nicola Lauria; Pierluca Piselli; Simone Lanini; Giuseppe Ippolito; Antonino Di Caro; Maria Rosaria Capobianchi
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

2.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  5' noncoding region alone does not unequivocally determine genetic type of human rhinovirus strains.

Authors:  Carita Savolainen-Kopra; Soile Blomqvist; Teemu Smura; Merja Roivainen; Tapani Hovi; David Kiang; Ishmeet Kalra; Shigeo Yagi; Janice K Louie; Homer Boushey; John Boothby; David P Schnurr
Journal:  J Clin Microbiol       Date:  2009-04       Impact factor: 5.948

5.  Enteroviruses and Rhinoviruses: Molecular Epidemiology of the Most Influenza-Like Illness Associated Viruses in Senegal.

Authors:  Amary Fall; Ndongo Dia; Ousmane Kébé; Fatoumata Diene Sarr; Davy E Kiori; El Hadj Abdoul Khadir Cissé; Sara Sy; Deborah Goudiaby; Vincent Richard; Ousmane Madiagne Diop; Mbayame Ndiaye Niang
Journal:  Am J Trop Med Hyg       Date:  2016-05-31       Impact factor: 2.345

Review 6.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections.

Authors:  Charles Y Chiu; Alexander L Greninger; Kimberly Kanada; Thomas Kwok; Kael F Fischer; Charles Runckel; Janice K Louie; Carol A Glaser; Shigeo Yagi; David P Schnurr; Tom D Haggerty; Julie Parsonnet; Don Ganem; Joseph L DeRisi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

8.  Severe rhinovirus pneumonia in a young woman taking performance-enhancing drugs.

Authors:  Kristina Nadine Mayer; Daniel Wyder; Danijela Spasic; Thomas Herren
Journal:  BMJ Case Rep       Date:  2016-01-06

9.  Long-term care facilities: a cornucopia of viral pathogens.

Authors:  Ann R Falsey; Gerard E Dallal; Maria A Formica; Gloria G Andolina; Davidson H Hamer; Lynette L Leka; Simin Nikbin Meydani
Journal:  J Am Geriatr Soc       Date:  2008-06-28       Impact factor: 5.562

Review 10.  The infectious march: the complex interaction between microbes and the immune system in asthma.

Authors:  Terianne Wong; Gary Hellermann; Shyam Mohapatra
Journal:  Immunol Allergy Clin North Am       Date:  2010-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.